BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: den Hartog GJ, Qi S, van Tilburg JH, Koek GH, Bast A. Superoxide anion radicals activate hepatic stellate cells after entry through chloride channels: a new target in liver fibrosis. Eur J Pharmacol. 2014;724:140-144. [PMID: 24378345 DOI: 10.1016/j.ejphar.2013.12.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Liang S, Kisseleva T, Brenner DA. The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts. Front Physiol. 2016;7:17. [PMID: 26869935 DOI: 10.3389/fphys.2016.00017] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
2 Mortezaee K, Khanlarkhani N. Melatonin application in targeting oxidative‐induced liver injuries: A review. J Cell Physiol 2018;233:4015-32. [DOI: 10.1002/jcp.26209] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
3 Liu Y, Nepali K, Liou J. Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. J Med Chem 2017;60:527-53. [DOI: 10.1021/acs.jmedchem.6b00935] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
4 Kaminskyy D, den Hartog GJ, Wojtyra M, Lelyukh M, Gzella A, Bast A, Lesyk R. Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones. European Journal of Medicinal Chemistry 2016;112:180-95. [DOI: 10.1016/j.ejmech.2016.02.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
5 Guo JW, Liu X, Zhang TT, Lin XC, Hong Y, Yu J, Wu QY, Zhang FR, Wu QQ, Shang JY, Lv XF, Ou JS, Zhou JG, Pang RP, Tang BD, Liang SJ. Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic Disorder. Adv Sci (Weinh) 2020;7:1903657. [PMID: 32440483 DOI: 10.1002/advs.201903657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
6 Zhao XM, Zhang J, Liang YN, Niu YC. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats. Dig Dis Sci 2020;65:2925-36. [PMID: 31900718 DOI: 10.1007/s10620-019-06017-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
7 Elpek GÖ. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014;20:7260-76. [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] [Cited by in CrossRef: 161] [Cited by in F6Publishing: 137] [Article Influence: 26.8] [Reference Citation Analysis]
8 Jessurun NT, Drent M, van Puijenbroek EP, Bekers O, Wijnen PA, Bast A. Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects. Current Opinion in Pulmonary Medicine 2019;25:468-77. [DOI: 10.1097/mcp.0000000000000590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ramírez A, Vázquez-Sánchez AY, Carrión-Robalino N, Camacho J. Ion Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver Diseases. Oxid Med Cell Longev 2016;2016:3928714. [PMID: 26881024 DOI: 10.1155/2016/3928714] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
10 Aitken RJ. Reactive oxygen species as mediators of sperm capacitation and pathological damage. Mol Reprod Dev 2017;84:1039-52. [DOI: 10.1002/mrd.22871] [Cited by in Crossref: 163] [Cited by in F6Publishing: 129] [Article Influence: 40.8] [Reference Citation Analysis]
11 Crosas-Molist E, Fabregat I. Role of NADPH oxidases in the redox biology of liver fibrosis. Redox Biol 2015;6:106-11. [PMID: 26204504 DOI: 10.1016/j.redox.2015.07.005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
12 Ampuero J, Romero-Gómez M. Assessing cardiovascular risk in hepatitis C: An unmet need. World J Hepatol. 2015;7:2214-2219. [PMID: 26380047 DOI: 10.4254/wjh.v7.i19.2214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
13 Liu Y, Long J, Liu J. Mitochondrial free radical theory of aging: who moved my premise? Geriatr Gerontol Int 2014;14:740-9. [PMID: 24750368 DOI: 10.1111/ggi.12296] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
14 Mortezaee K, Majidpoor J, Daneshi E, Abouzaripour M, Abdi M. Post‐treatment of melatonin with CCl 4 better reduces fibrogenic and oxidative changes in liver than melatonin co‐treatment. J Cell Biochem 2018;119:1716-25. [DOI: 10.1002/jcb.26331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]